Anna Brown
@annajbrown.bsky.social
📤 70
📥 163
📝 6
London-based reporter for Endpoints News |
[email protected]
| Signal annabrown.04
pinned post!
Hello! Still in the process of moving over to Bluesky, for new friends: I write about biomanufacturing and supply chains over at
@endpts.com
-- feel free to reach out at
[email protected]
for tips or just to say hi! A taster of some manufacturing news today:
endpts.com/pfizers-manu...
loading . . .
Pfizer’s manufacturing arm at risk from Trump tariffs in Europe, Bourla says
Pfizer CEO Albert Bourla said its manufacturing business could be vulnerable from President Donald Trump’s tariffs in Europe as the big pharma has
https://endpts.com/pfizers-manufacturing-arm-at-risk-from-trump-tariffs-in-europe-bourla-says/
8 months ago
1
1
0
reposted by
Anna Brown
Andrew Dunn
5 months ago
Here's something new: our first-ever Post-Hoc Live happens tomorrow at noon ET Watch
@drewsnews.bsky.social
,
@maxbayer.bsky.social
and
@annajbrown.bsky.social
talk pharma & tariffs — while live!
endpts.com/how-pharma-i...
loading . . .
How pharma is reacting to ‘Liberation Day’: Join us tomorrow for Post-Hoc Live!
Live stream podcast tomorrow at 12pm ET with Drew Armstrong, Max Bayer & Anna Brown discussing pharma industry's response to Trump administration tariffs, including lobbying & manufacturing changes.
https://endpts.com/how-pharma-is-reacting-to-liberation-day-endpoints-livestream/
0
1
3
reposted by
Anna Brown
Max Gelman
6 months ago
Johnson & Johnson CEO Joaquin Duato subtly but assertively criticized President Donald Trump's plans for pharmaceutical tariffs, saying tax policy is a better way to onshore US drug manufacturing.
endpts.com/jj-ceo-chide...
loading . . .
J&J's Duato says 'not tariffs, but tax policy' is best way to boost US manufacturing
The Johnson & Johnson CEO subtly but assertively criticized the Trump administration’s plans for pharmaceutical tariffs, saying they are not an effective tool to onshore drug manufacturing to the US.
https://endpts.com/jj-ceo-chides-trumps-tariff-plan-to-boost-us-drugmaking/
0
1
3
While Trump has launched a 232 investigation to tax pharmaceuticals, he's simultaneously issued an executive order to lower US drug prices. See
@zacharybrennan.bsky.social
coverage on this at
@endpts.com
:
endpts.com/trump-pledge...
loading . . .
Trump pledges his support for a change to the IRA long sought by drugmakers
Trump signs EO on drug pricing, supports PhRMA reforms for Medicare negotiations timeline, calls for Canadian drug imports, and includes 340B program changes for EpiPens and insulin.
https://endpts.com/trump-pledges-support-for-changing-ira-pill-penalty-siding-with-pharma/
6 months ago
0
3
4
Pharma tariffs are likely to leave little room to hide for companies as the 232 investigation hits all the major parts of the supply chain:
endpts.com/trumps-pharm...
loading . . .
Pharma tariffs could leave little room to hide with sweeping probe underway
A US trade probe into pharmaceuticals is underway. And it’s hitting many of the key aspects of the supply chain.
https://endpts.com/trumps-pharma-probe-sweeps-in-apis-key-starting-materials/
6 months ago
0
2
0
Yesterday I wrote a piece for
@endpts.com
on what Trump's potential tariff rollout could look like for pharmaceuticals:
endpts.com/pharma-tarif...
But CDMOs seem more concerned with the current FDA staff cutbacks delaying inspections:
endpts.com/cdmos-antici...
loading . . .
Pharma tariffs: Here’s what a potential rollout could look like
Trump signals imminent pharma tariffs, with experts including Mollie Sitkowski of Faegre Drinker suggesting 25% levy possible. China's API exports to US could face major impact.
https://endpts.com/pharma-tariffs-heres-what-a-potential-rollout-could-look-like/
6 months ago
0
3
0
reposted by
Anna Brown
Liz Essley Whyte
6 months ago
Former FDA Commissioner:
27
1048
398
reposted by
Anna Brown
Endpoints News
6 months ago
🚨 Breaking: Firings swept across the FDA, gutting leadership and whole offices, as some staff found out their jobs were cut when they showed up to work on Tuesday.
endpts.com/firings-swee...
loading . . .
Breaking: Firings sweep across FDA, gutting leadership and whole offices
Mass firings and forced resignations swept through the FDA on Tuesday, as part of thousands of planned job cuts at federal health agencies being implemented by the Trump administration.
https://endpts.com/firings-sweep-across-fda-gutting-leadership-and-whole-offices/?utm_source=Twitter&utm_medium=organic_social&utm_campaign=editorial&utm_content=
2
2
2
Ahead of potential pharmaceutical tariffs next week,
@maxbayer.bsky.social
broke down what this could mean for the industry
@endpts.com
:
endpts.com/trump-pharma...
loading . . .
Three major questions on pharma tariffs Trump claims are on the way
Trump threatens pharma tariffs on foreign-made drugs, particularly targeting Ireland. Industry faces potential $63B annual tariff increase per PwC. Eli Lilly, J&J, AstraZeneca boost US investment.
https://endpts.com/trump-pharma-tariffs-details-on-impact-and-timing/
6 months ago
0
3
0
reposted by
Anna Brown
Zachary Brennan
7 months ago
DOGE terminates lease on FDA pharma quality lab in St. Louis that employs about 70 scientists - unclear on their fate
endpts.com/doge-shutter...
loading . . .
DOGE terminates lease on FDA quality lab in St. Louis, and 29 other sites
DOGE says that it has terminated the leases of 30 FDA offices and buildings, including a 52,000 square-foot St. Louis-based lab that operates under the FDA's Office of Pharmaceutical Quality.
https://endpts.com/doge-shutters-lease-on-fda-lab-in-st-louis-and-29-other-sites/
0
8
7
Endpoints weekly manufacturing newsletter's out today, leading with our story on Lilly's $27 billion manufacturing push in the US from
@zacharybrennan.bsky.social
endpts.com/lilly-says-i...
loading . . .
Updated: Lilly joins Trump administration to announce $27B manufacturing commitment
WASHINGTON — Eli Lilly touted a huge new US manufacturing investment at an event on Wednesday, trotting out the news with a member of President Donald Trump’s cabinet as part of ...
https://endpts.com/lilly-says-it-will-invest-27b-into-us-drug-manufacturing/
7 months ago
0
1
0
reposted by
Anna Brown
Zachary Brennan
7 months ago
We are too! DM me or find me on Signal at zacharybrennan.20
add a skeleton here at some point
0
16
12
reposted by
Anna Brown
Zachary Brennan
7 months ago
Some of the user fee-funded staff at FDA were reinstated on Monday, after being laid off about a week ago for dubious reasons. 183 of the 230 staffers initially let go were supported by the user fee program
endpts.com/some-fda-med...
loading . . .
Some FDA medical device staff reinstated just days after receiving pink slips
Some of the more than 200 staffers laid off at the FDA's Center for Devices and Radiological Health (CDRH) returned to work Monday, about a week after hearing their roles would be cut, several device ...
https://endpts.com/some-fda-medical-device-staff-reinstated-just-days-after-firings/
0
4
5
reposted by
Anna Brown
The Guardian
7 months ago
Amanda Pritchard quits as NHS England chief executive in shock move
loading . . .
Amanda Pritchard quits as NHS England chief executive in shock move
Exclusive: Departure follows meetings with Wes Streeting and unusual criticism from two Commons committees Amanda Pritchard is standing down as chief executive of NHS England, in a development that will shock the health service. Her departure from the…
https://www.theguardian.com/society/2025/feb/25/amanda-pritchard-quits-nhs-england-chief-executive?utm_source=dlvr.it&utm_medium=bluesky&CMP=bsky_gu
7
66
32
reposted by
Anna Brown
Sheryl Gay Stolberg
8 months ago
Young scientists, doctors, and public health professionals who earned prestigious federal fellowships are getting the axe from Trump. Is this how to plan for the next pandemic? “We owe them a debt of gratitude, not a pink slip,” former agency heads said.
www.nytimes.com/2025/02/18/u...
loading . . .
Trump Cuts Target Next Generation of Scientists and Public Health Leaders
A core group of so-called disease detectives, who track outbreaks, was apparently spared. But other young researchers are out of jobs.
https://www.nytimes.com/2025/02/18/us/politics/fda-cdc-health-department-trump.html
5
169
68
reposted by
Anna Brown
Andrew Dunn
8 months ago
Pfizer CEO Bourla: “Do I think we can convince them to do something bold in vaccines with Kennedy in HHS? Probably not. But do I think that we can convince them to do something very bold for cancer or for cardiovascular diseases with Kennedy in HHS? Absolutely I do.”
endpts.com/pfizer-ceo-s...
loading . . .
Pfizer CEO says opportunities with Trump ‘clearly outweigh’ the risks for pharma
Over 500 pharma executives, lobbyists, consultants and other industry members gathered a couple miles from the White House on Tuesday, as top industry leaders took the stage and tried out some new mes...
https://endpts.com/pfizer-ceo-says-trump-opportunities-outweigh-risks/
0
1
3
reposted by
Anna Brown
Chris Geidner
8 months ago
BREAKING: Nonprofits sue over Trump's anti-diversity, anti-trans executive orders, alleging they violate the First Amendment & equal protection guarantees, are void for vagueness, exceed the president's authority, & violate the Administrative Procedure Act.
storage.courtlistener.com/recap/gov.us...
19
3453
1021
Hello! Still in the process of moving over to Bluesky, for new friends: I write about biomanufacturing and supply chains over at
@endpts.com
-- feel free to reach out at
[email protected]
for tips or just to say hi! A taster of some manufacturing news today:
endpts.com/pfizers-manu...
loading . . .
Pfizer’s manufacturing arm at risk from Trump tariffs in Europe, Bourla says
Pfizer CEO Albert Bourla said its manufacturing business could be vulnerable from President Donald Trump’s tariffs in Europe as the big pharma has
https://endpts.com/pfizers-manufacturing-arm-at-risk-from-trump-tariffs-in-europe-bourla-says/
8 months ago
1
1
0
reposted by
Anna Brown
George Conway 👊🇺🇸🔥
8 months ago
We’ve seen this movie before.
add a skeleton here at some point
554
16701
3249
reposted by
Anna Brown
Endpoints News
8 months ago
Pfizer’s contract manufacturing arm operates 12 facilities in Europe. CEO Albert Bourla warned that the business could be vulnerable to tariffs on European imports proposed during Donald Trump’s presidency.
loading . . .
Pfizer’s manufacturing arm at risk from Trump tariffs in Europe, Bourla says
Pfizer CEO Albert Bourla said its manufacturing business could be vulnerable from President Donald Trump’s tariffs in Europe as the big pharma has
https://endpts.com/pfizers-manufacturing-arm-at-risk-from-trump-tariffs-in-europe-bourla-says/?utm_medium=organic_social&utm_campaign=gatedarticle&utm_source=bluesky&utm_content=&utm_term=
1
2
2
you reached the end!!
feeds!
log in